GREAT NEWS
The phase II UK trial of Sativex in globlastomas will open in March 2022. TBTC campaign to fund this trial has received an outpouring of public support, which has resulted in over £400,000 raised in just 3 months. More info can be found in the news section of the TBTC website.
The phase II UK trial of Sativex in globlastomas will open in March 2022. TBTC campaign to fund this trial has received an outpouring of public support, which has resulted in over £400,000 raised in just 3 months. More info can be found in the news section of the TBTC website.